Tvardi Therapeutics Inc (TVRD) Stock Price, Quote, News & History

TVRDNASDAQ
$1.33
0.064.72%
At close: Sep 28, 5:00 PM EST
$1.31
-0.02-1.5%
After Hours: 4:53 PM EST

Tvardi Therapeutics (TVRD) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.03M
Investing Cash Flow (TTM)
20.47M
Financing Cash Flow (TTM)
-321.00K
Free Cash Flow (TTM)
-25.03M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-4.88M

Analyst Trends and Forecast

1
2
1
Apr
1
Jun
3
Jul
1
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.45M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
2.04
Earnings Yield % (TTM)
-225.98%
Earnings Yield % (FWD)
-301.97%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.63

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$15.77M
Debt to Equity
0.02
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.27
Close
$1.33
Volume / Avg.
351.24K / 2.30M
Day Range
$1.19 - $1.37
52 Wk Range
0.93 - 43.65
Market Cap
$17.47M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
1.92%
Days to Cover
2.29

About

Sector
Health Care
Industry
Pharmaceuticals
Tvardi Therapeutics Inca clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting Signal Transducer and Activator of Transcription 3 (STAT3) to treat inflammatory and proliferative disease...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Tvardi Therapeutics (TVRD) stock?

A

You can purchase shares of Tvardi Therapeutics (NASDAQ:TVRD) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Tvardi Therapeutics (TVRD) competitors?

Q

What is the forecast, or price target, for Tvardi Therapeutics (TVRD) stock?

A

Tvardi Therapeutics has a consensus price target of $11.86.

Q

What is the current price for Tvardi Therapeutics (TVRD)?

A

The stock price for Tvardi Therapeutics (NASDAQ: TVRD) is $1.31 last updated September 28, 2026 at 4:53 PM EDT.

Q

Does Tvardi Therapeutics (TVRD) pay a dividend?

A

There are no upcoming dividends for Tvardi Therapeutics.

Q

When is Tvardi Therapeutics (NASDAQ:TVRD) reporting earnings?

A

Tvardi Therapeutics does not have any upcoming earnings scheduled.

Q

Is Tvardi Therapeutics (TVRD) going to split?

A

There is no upcoming split for Tvardi Therapeutics.

Q

What sector and industry does Tvardi Therapeutics (TVRD) operate in?

A

Tvardi Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.